Evidence map›Paper›PMID 28592536›Full record

ArticleJournal of virology2017

Evasion of the STING DNA-Sensing Pathway by VP11/12 of Herpes Simplex Virus 1.

Thibaut Deschamps, Maria Kalamvoki

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 94 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Co-option of mitochondrial nucleic acid-sensing pathways by HSV-1 UL12.5 for reactivation from latent infection.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Gyrovirus: current status and challenge.Frontiers in microbiology · 2024
    Review
  12. Article
  13. Article
  14. The Many Ways to Deal with STING.International journal of molecular sciences · 2023
    Review
  15. Unlocking STING as a Therapeutic Antiviral Strategy.International journal of molecular sciences · 2023
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Thibaut DeschampsUniversity of Kansas Medical Center, Department of Microbiology, Molecular Genetics, and Immunology, Kansas City, Kansas, USA.
Maria KalamvokiUniversity of Kansas Medical Center, Department of Microbiology, Molecular Genetics, and Immunology, Kansas City, Kansas, USA mkalamvoki@kumc.edu.
University of Kansas Medical Center · US

Funding

Synthetic Chemical Biology CoreP20GM113117 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI OROZCO, ROBIN C. · 2016 to 2025
$23.9M
NIGMS NIH HHS P20 GM113117
6 · The paper itself

Abstract

The

Indexed as

Immune EvasionAntigens, ViralCell LineDNA, ViralEpithelial CellsHerpesvirus 1, HumanHumansMembrane ProteinsSTING ProteinViral ProteinsAntigens, ViralDNA, ViralMembrane ProteinsSTING1 protein, humanSTING ProteinUL46 protein, Human herpesvirus 1Viral ProteinsDNA sensorsherpes simplex virusIFI16innate immunitySTINGUL46 (VP11/12)VP11/12 (UL46)

Identifiers

PMID28592536
PMCPMC5533902
OpenAlexW2803892206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.